<?xml version="1.0" encoding="UTF-8"?>
<p>Currently, the lack of approved vaccines to inducing active immunity calls for the prompt development and deployment of passive immunization approaches for prophylactic and therapeutic treatment of patients. Convalescent plasma treatment using plasma-containing antibodies from recovered patients would be the empirical and timeliest therapy during the outbreak of COVID-19. Reports have shown a shorter hospital stay and reduced rate of mortality in convalescent plasma-treated SARS-CoV patients compared with the untreated individuals.
 <sup>
  <xref rid="cit0073" ref-type="bibr">73</xref>,
  <xref rid="cit0074" ref-type="bibr">74</xref>
 </sup> If found effective, then he plasma banks with volunteer blood donation by a large number of recovered COVID-19 people should be established promptly.
</p>
